Blood sugar levels in youngsters with type 1 diabetes improved during Britain’s first national COVID-19 pandemic lockdown, researchers say. “Children and families found it easier to manage this disease when they were forced to stay at home. This helps us to understand the pressure that is put on patients and families when trying to live… read on > read on >
The first drug approved in the United States to treat thyroid eye disease may come with an unwelcome side effect for many: A small, new study finds that up to two-thirds of patients who take the medication experience hearing problems. Teprotumumab (Tepezza) was approved by the U.S. Food and Drug Administration in January 2020. In… read on > read on >
Cancer survivors, especially older ones, have an increased risk of heart disease over the next decade, a new study finds. Ohio State University researchers analyzed data from more than 15,000 U.S. adults, aged 40 to 79, who were followed from 2007 to 2016. At the start of the study period, 13% reported a history of… read on > read on >
Despite the fact that Americans have been driving less during the pandemic, pedestrian deaths per mile in the United States spiked 20% in the first half of 2020, new research shows. The culprits? Increases in speeding, distracted and impaired driving, and other dangerous driving behaviors, researchers said. Factoring in a 16.5% reduction in vehicle miles… read on > read on >
For those who suffer painful arthritis in their aging knees, new research suggests a noninvasive treatment might deliver lasting relief. Called genicular artery embolization, the roughly two-hour catheter treatment involves a once-and-done injection of tiny hydrogel particles into arterial pathways in the knee joint. The goal: To decrease overall blood flow in the joint, and… read on >
Daily insulin jabs can be the bane of existence for people who live with type 2 diabetes, but an investigational once-weekly insulin shot may be a game changer for these folks. While the research is still in its early stages, the new drug called basal insulin Fc (BIF) is given once a week and appears… read on > read on >
States that make marijuana a readily available retail item might see an increase in self-harm among younger men, a new study suggests. Researchers found a correlation between U.S. states’ shifting marijuana policies and rates of self-harm among men younger than 40. Those rates — which include suicide attempts and non-suicidal behaviors like cutting — increased… read on > read on >
MONDAY, March 22, 2021 (American Heart Association News) — A study of Black Americans who kept their blood pressure healthy as they aged could help pinpoint the best ways to prevent hypertension before it starts. Hypertension, or high blood pressure, is a widespread problem among Black people in the U.S., said Shakia Hardy, assistant professor… read on > read on >
Looking to shed some of those pandemic pounds? A new analysis says wearables like Fitbit and Apple Watch can help people slim down. The researchers examined studies involving commercial health wearables and adults who were overweight/obese or had a chronic health condition. After daily moderate-to-vigorous physical activity for a period between a month and a… read on > read on >
AstraZeneca’s coronavirus vaccine was 79 percent effective in protecting against COVID-19 infection in a large U.S. clinical trial, the company announced Monday. The findings may help restore confidence in the vaccine that was lost recently after more than a dozen countries, mostly in Europe, suspended use of the shot following reports of rare blood clots.… read on > read on >
